Parkinson's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with Parkinson's disease.
- People who are between 50 and 80 years of age.
- People whose Parkinson's disease falls within a mild-to-moderate range of progression, as measured by a standard medical scale called the Modified Hoehn and Yahr (stages 1.5 to 3) (confirm with trial site).
- People who have been on a stable medication routine for the past 3 months.
- People who score above 23 on a standard memory and thinking assessment called the Mini-Mental State Examination (confirm with trial site).
- People who have read and signed an informed consent form agreeing to take part in the trial.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are younger than 50 or older than 80 years of age.
- People who have bone or joint problems, severe arthritis, nerve damage in the legs or feet, or a history of joint replacement surgery in the lower limbs.
- People who have heart or blood vessel disease, particularly very high blood pressure (above 180/110 mmHg while at rest) in the last four weeks, or who have recently had a heart attack.
- People who experience a significant drop in blood pressure when standing up (a condition called orthostatic hypotension).
- People who weigh more than 100 kg.
- People who have a disease affecting the lungs or breathing.
- People who experience severe involuntary movements, significant vision problems, or poorly controlled "on-off" episodes related to their Parkinson's disease (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Emre Ata, Ass.Prof, Sultan 2. Abdülhamid Han Training and Research Hospital
Phone: 05395955090
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
Biodex
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.